QuantumLead homepage Docking Virtual Ligand Screening

Docking, Virtual Ligand Screening

Quantum is a leading company providing virtual screening services. We apply our proprietary computational docking technology QUANTUM to identify potential ligands for a given protein target. QUANTUM shows outstanding accuracy in forecasting binding affinities of protein ligands. The hit rate of the virtual screening produced by QUANTUM is in range of 10 - 50%.

We specialize in identifying proper 3D-structure of the target-protein and advise you regarding which libraries of compounds should be chosen for virtual screening. If 3D structure of the protein of your choice is not available, or not exist, then we can build its 3D force field homology model, which can be further used for virtual screening.

Docking Virtual Screening pictureQUANTUM hit Identification technology
Virtual Ligand Screening pictureQUANTUM technology advantages
QUANTUM technology description and a summary of the key capabilities

Quantum can assist in analyzing drug hits and in initiating hit-to-lead programs. Please, contact Quantum to discuss your virtual screening project.

Use this form to contact us and inquire about Quantum's virtual screening services. Please fill in your email address and expect our representative contact you.

email:


Home
Small Molecules: Hit identification
Small Molecules: Hit-to-Lead optimization
Small Molecules: physicochemical properties
Small Molecules: ADME
Small Molecules: Toxicity
Small Molecules: Selectivity
Antibodies: Humanization and Optimization
Protein Modeling. Discovery
Protein Modeling: HERG binding
Protein Modeling: Albumin binding
Out-licensing. Drug Discovery Products

Design by netrider.ru , 2004 Docking | Virtual Screening |Ligand Virtual Screening